Tag: IT-103

April 5, 2017

Marina Biotech Gives Business Update

Marina Biotech released a corporate update detailing recent changes in the company and some corporate highlights, following the filing of...
April 3, 2017

Marina Biotech Signs Deal To Make Bi-Layer Tablet

Marina Biotech signed an agreement with Windlas Healthcare Limited to manufacture IT-102 fixed-dose combination bi-layer tablets.
March 29, 2017

Marina Biotech To Show New Research At Cancer Meeting

Marina Biotech will showcase new scientific information on the use of IT-102 and IT-103 for cancer treatment during the American...
March 24, 2017

Marina Biotech Will Show New Data on Cancer Treatment

Marina Biotech (OTCQB:MRNA) will present new information on the use of antihypertensive for the treatment of cancer by targeting vascular...